Catalyst Wire Dossier Catalyst Wire Dossier

Budesonide targeted-release formulation

budesonide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Budesonide targeted-release formulation, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

See pricing